Co-Diovan

País: Nova Zelândia

Língua: inglês

Origem: Medsafe (Medicines Safety Authority)

Ingredientes ativos:

Hydrochlorothiazide 25mg (micronized);  ; Valsartan 320mg;  ;  ;  

Disponível em:

Novartis New Zealand Ltd

DCI (Denominação Comum Internacional):

Hydrochlorothiazide 25 mg (micronized)

Dosagem:

320mg/25mg

Forma farmacêutica:

Film coated tablet

Composição:

Active: Hydrochlorothiazide 25mg (micronized)   Valsartan 320mg       Excipient: Colloidal silicon dioxide Crospovidone Hypromellose Iron oxide yellow Macrogol 4000 Magnesium stearate Microcrystalline cellulose Purified talc Titanium dioxide

Unidades em pacote:

Blister pack, PVC/PVDC/Alu foil, 28 tablets

Classe:

Prescription

Tipo de prescrição:

Prescription

Fabricado por:

Novartis Pharma Schweizerhalle AG

Indicações terapêuticas:

Co-Diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. These fixed dose combinations should be used as second line.

Resumo do produto:

Package - Contents - Shelf Life: Blister pack, PA/Al/PVC foil - 28 tablets - 36 months from date of manufacture stored at or below 30°C protect from moisture - Blister pack, PVC/PVDC/Alu foil - 28 tablets - 36 months from date of manufacture stored at or below 25°C

Data de autorização:

2006-03-03